148 related articles for article (PubMed ID: 24521357)
1. MiR-200a inhibits epithelial-mesenchymal transition of pancreatic cancer stem cell.
Lu Y; Lu J; Li X; Zhu H; Fan X; Zhu S; Wang Y; Guo Q; Wang L; Huang Y; Zhu M; Wang Z
BMC Cancer; 2014 Feb; 14():85. PubMed ID: 24521357
[TBL] [Abstract][Full Text] [Related]
2. Pancreatic cancers epigenetically silence SIP1 and hypomethylate and overexpress miR-200a/200b in association with elevated circulating miR-200a and miR-200b levels.
Li A; Omura N; Hong SM; Vincent A; Walter K; Griffith M; Borges M; Goggins M
Cancer Res; 2010 Jul; 70(13):5226-37. PubMed ID: 20551052
[TBL] [Abstract][Full Text] [Related]
3. Targeting miRNAs involved in cancer stem cell and EMT regulation: An emerging concept in overcoming drug resistance.
Wang Z; Li Y; Ahmad A; Azmi AS; Kong D; Banerjee S; Sarkar FH
Drug Resist Updat; 2010; 13(4-5):109-18. PubMed ID: 20692200
[TBL] [Abstract][Full Text] [Related]
4. Motility and stem cell properties induced by the epithelial-mesenchymal transition require destabilization of lipid rafts.
Tisza MJ; Zhao W; Fuentes JS; Prijic S; Chen X; Levental I; Chang JT
Oncotarget; 2016 Aug; 7(32):51553-51568. PubMed ID: 27303921
[TBL] [Abstract][Full Text] [Related]
5. A concise review on the current understanding of pancreatic cancer stem cells.
Vaz AP; Ponnusamy MP; Seshacharyulu P; Batra SK
J Cancer Stem Cell Res; 2014; 2():. PubMed ID: 26451384
[TBL] [Abstract][Full Text] [Related]
6. Molecular biomarkers of cancer stem/progenitor cells associated with progression, metastases, and treatment resistance of aggressive cancers.
Mimeault M; Batra SK
Cancer Epidemiol Biomarkers Prev; 2014 Feb; 23(2):234-54. PubMed ID: 24273063
[TBL] [Abstract][Full Text] [Related]
7. The miR-200 Family of microRNAs: Fine Tuners of Epithelial-Mesenchymal Transition and Circulating Cancer Biomarkers.
Cavallari I; Ciccarese F; Sharova E; Urso L; Raimondi V; Silic-Benussi M; D'Agostino DM; Ciminale V
Cancers (Basel); 2021 Nov; 13(23):. PubMed ID: 34884985
[TBL] [Abstract][Full Text] [Related]
8. Synergistic reversal effect of epithelial-to-mesenchymal transition by miR-223 inhibitor and genistein in gemcitabine-resistant pancreatic cancer cells.
Ma J; Zeng F; Ma C; Pang H; Fang B; Lian C; Yin B; Zhang X; Wang Z; Xia J
Am J Cancer Res; 2016; 6(6):1384-95. PubMed ID: 27429851
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of Tumorigenic Properties of MDA-MB-231 Cancer Stem Cells Cocultured with Telocytes and Telocyte-Derived Mitochondria Following
Babadag S; Altundag-Erdogan Ö; Akkaya-Ulum YZ; Çelebi-Saltik B
DNA Cell Biol; 2024 Apr; ():. PubMed ID: 38634821
[TBL] [Abstract][Full Text] [Related]
10. Mesenchymal-like pancreatic cancer cells harbor specific genomic alterations more frequently than their epithelial-like counterparts.
Sinha A; Cherba D; Bartlam H; Lenkiewicz E; Evers L; Barrett MT; Haab BB
Mol Oncol; 2014 Oct; 8(7):1253-65. PubMed ID: 24837184
[TBL] [Abstract][Full Text] [Related]
11. Surface-Enhanced Raman Spectroscopy-Based Detection of EMT-Related Targets in Endometrial Cancer: Potential for Diagnosis and Prognostic Prediction.
Ma Y; Ma R; Zhang Z; Jiang H; Li Y; Jiang S; Li Y
Anal Chem; 2024 May; ():. PubMed ID: 38780221
[TBL] [Abstract][Full Text] [Related]
12. Nanomaterials as Inhibitors of Epithelial Mesenchymal Transition in Cancer Treatment.
Cordani M; Strippoli R; Somoza Á
Cancers (Basel); 2019 Dec; 12(1):. PubMed ID: 31861725
[No Abstract] [Full Text] [Related]
13. Delivery of Protein Kinase A by CRISPRMAX and Its Effects on Breast Cancer Stem-Like Properties.
Zhou JN; Rautio TC; Liu C; Xu XY; Wang DQ; Guo Y; Eriksson J; Zhang H
Pharmaceutics; 2020 Dec; 13(1):. PubMed ID: 33374889
[TBL] [Abstract][Full Text] [Related]
14. Epithelial-Mesenchymal Transition and Its Regulation Mechanisms in Pancreatic Cancer.
Luu T
Front Oncol; 2021; 11():646399. PubMed ID: 33928036
[TBL] [Abstract][Full Text] [Related]
15. The consistent anti-cancer effect of a simple exercise (Ou MC decrescendo phenomenon exercise) may hold promise for low-cost cancer prevention.
Ou MC; Chen FM
Ann Med Surg (Lond); 2024 Apr; 86(4):2137-2142. PubMed ID: 38576944
[TBL] [Abstract][Full Text] [Related]
16. Down-regulation of miR-223 reverses epithelial-mesenchymal transition in gemcitabine-resistant pancreatic cancer cells.
Ma J; Fang B; Zeng F; Ma C; Pang H; Cheng L; Shi Y; Wang H; Yin B; Xia J; Wang Z
Oncotarget; 2015 Jan; 6(3):1740-9. PubMed ID: 25638153
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of miR-200a suppresses epithelial-mesenchymal transition of liver cancer stem cells.
Wang J; Yang X; Ruan B; Dai B; Gao Y; Duan J; Qu S; Tao K; Dou K; Li H
Tumour Biol; 2015 Apr; 36(4):2447-56. PubMed ID: 25412960
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-200 family members and ZEB2 are associated with brain metastasis in gastric adenocarcinoma.
Minn YK; Lee DH; Hyung WJ; Kim JE; Choi J; Yang SH; Song H; Lim BJ; Kim SH
Int J Oncol; 2014 Dec; 45(6):2403-10. PubMed ID: 25270520
[TBL] [Abstract][Full Text] [Related]
19. A novel saliva-based microRNA biomarker panel to detect head and neck cancers.
Salazar C; Nagadia R; Pandit P; Cooper-White J; Banerjee N; Dimitrova N; Coman WB; Punyadeera C
Cell Oncol (Dordr); 2014 Oct; 37(5):331-8. PubMed ID: 25156495
[TBL] [Abstract][Full Text] [Related]
20. MicroRNAs as the critical regulators of epithelial mesenchymal transition in pancreatic tumor cells.
Tolue Ghasaban F; Ghanei M; Mahmoudian RA; Taghehchian N; Abbaszadegan MR; Moghbeli M
Heliyon; 2024 May; 10(9):e30599. PubMed ID: 38726188
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
